first glp 1 approval Figure 2, Health Canada Timeline for GLP-1 Receptor Agonists by Marketed Date and NOC Dates - Formulary Management of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists Clinical Capsules: Semaglutide Becomes the

Approved Medical Uses: Prevention & Treatment of B12 Deficiency: Corrects low B12 due to poor nutrition, GI disorders, or malabsorption

CPT Code 99212: Evaluation and Management Description Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three components to be present in the medical record: A problem focused history A problem focused examination Decision making regarding treatment is straightforward Usually, the presenting problem(s) treatment is straightforward

Mulberry fruit ameliorates Parkinsons-disease-related pathology by reducing alpha-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model

Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Fellermann K, Ganz T, Stange EF, Bevins CL: Reduced Paneth cell -defensins in ileal Crohn's disease

The mechanism also appears to preserve lean muscle mass, as the peptide does not promote protein catabolism or interfere with muscle protein synthesis pathways